Specialty
Aesthetics Cardiology Cataract & Refractive Dermatology General Ophthalmology Glaucoma Interventional Cardiology Interventional Radiology Neurology Optometry Retina Women's Health View All Courses
Course Type
Supplement Multimedia Webinar In-Person Multi-Part Collection
Search
Log In

Evolving Concepts in Anterior Segment Outcomes: Tackling Ocular Surface Disease Video Interview

By: Doug K. Devries, OD

Webinar Credits: .25

In this video interview, Douglas K. Devries, OD, discusses the negative impact of undiagnosed and untreated ocular surface disease. He give pearls for comanaging cataract surgery patients, screening for meibomian gland dysfunction, and approaching OSD management in patients with comorbid conditions.

Expiration Date: Wednesday, June 14, 2023
Release Date: June 21, 2020

Learning Objectives

    1. Identify methods to improve surgical, and ocular surface and corneal disease outcomes through comanagement of cataract, refractive, and corneal patients
    2. Describe the impact that OSD has on contact lens wear and drop out as well as overall cataract and refractive surgery outcomes
    3. Compare and contrast traditional and new and emerging diagnostic tests in classifying ocular surface disease severity and differentiating MGD
    4. Increase confidence in making therapeutic decisions for OSD patients based on disease classification, including acute exacerbations of dry eye disease, chronic dry eye, and MGD
    5. Explore approaches to ocular surface toxicity when OSD patients are treated for comorbid conditions

Accreditation and Designation Statement

This course is COPE approved for .5 hour of CE credit for optometrists.

Sponsored by State University of New York School of Optometry Office of Continuing Professional Education

Evolve is an approved COPE Administrator.

COPE Course ID: 68413-AS

COPE Event ID: #119761

Faculty and Disclosures

Douglas K. Devries, OD, Moderator
Co-Founder and Managing Partner
Eye Care Associates of Nevada
Sparks, Nevada

DISCLOSURE POLICY:
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of
this educational activity. Evolve has full policies in place that will identify and resolve all conflicts of interest prior to this educational activity.

The following faculty/staff members have the following financial relationships with commercial interests:

Douglas K. Devries, OD, and/or spouse had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant and Speakers Bureau: Alcon, Bausch+ Health, Bio Tissue, Dompe, Eyevance, Johnson & Johnson Vision, Lumeris, Novartis, OcuSoft, Sun, and TearLab, Share/Stockholder: RPS.

EDITORIAL DISCLOSURES

Erin K. Fletcher, MIT, director of compliance and education; Evolve; and Kate Fehlhaber, PhD, writer, have no financial relationships with commercial interests.

 

Disclaimer

OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, Alcon, Carl Zeiss Meditec, Glaukos, or Johnson & Johnson Vision.

Pretest

Video Resources

By: Doug K. Devries, OD

Next

Test

Instructions

Step 1 of 2

  • AgreeNeutralDisagree
    a. Identify methods to improve surgical, and ocular surface and corneal disease outcomes through comanagement of cataract, refractive, and corneal patients
    b. Describe the impact that OSD has on contact lens wear and drop out as well as overall cataract and refractive surgery outcomes
    c. Compare and contrast traditional and new and emerging diagnostic tests in classifying ocular surface disease severity and differentiating MGD
    d. Increase confidence in making therapeutic decisions for OSD patients based on disease classification, including acute exacerbations of dry eye disease, chronic dry eye, and MGD
    e. Explore approaches to ocular surface toxicity when OSD patients are treated for comorbid conditions
Back